NEWS AND PRESS RELEASES

Probiotics may help manage childhood obesity

Sep 2020

Probiotics may help children and adolescents with obesity lose weight when taken alongside a calorie-controlled diet, according to a study being presented at e-ECE 2020. The study found that obese children who were put on a calorie-restricted diet and given probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, lost more weight and had improved insulin sensitivity compared with children on a diet only. These findings suggest that probiotic supplements and a calorie-controlled diet may help manage obesity in the younger population and reduce future health risks, such as heart disease and diabetes.

Probiotics may help children and adolescents with obesity lose weight when taken alongside a calorie-controlled diet, according to a study being presented at e-ECE 2020. The study found that obese children who were put on a calorie-restricted diet and given probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, lost more weight and had improved insulin sensitivity compared with children on a diet only. These findings suggest that probiotic supplements and a calorie-controlled diet may help manage obesity in the younger population and reduce future health risks, such as heart disease and diabetes.

Obesity is a global health concern and can lead to a number of life-threatening conditions, such as diabetes and heart disease. Treatment and prevention is a serious public health challenge, especially in children and adolescents. Bifidobacteria are a group of probiotic bacteria that are part of the natural gut microbiome and help with preventing infection from other bacteria, such as E.coli, and digestion of carbohydrates and dietary fibre. During digestion, they release chemicals called short-chain fatty acids, which play an important role in gut health and controlling hunger. Low numbers of Bifodobacteria may impair digestion, affect food intake and energy expenditure, leading to body weight gain and obesity.

Previous studies suggested that probiotic supplementation with Bifidobacteria could help restore the composition of the gut microbiome, which may aid weight loss and could be a potential approach for obesity management. However, current research uses mixtures of different strains of probiotics and does not examine the effects of administering Bifidobacteria alone.

Dr Flavia Prodam and her team at the University of Piemonte Orientale, aimed to assess the impact of Bifidobacteria probiotic treatment in children and adolescents with obesity on a controlled diet, on weight loss and gut microbiota composition. 100 obese children and adolescents (6-18 years) were put on a calorie-controlled diet and randomly given either probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, or a placebo for 8 weeks. Clinical, biochemical and stool sample analyses were carried out to determine the effect of probiotic supplementation on weight gain, gut microbiota and metabolism.
The results suggested that children who had taken probiotics had a reduction in waist circumference, BMI, insulin resistance and E.coli in their gut. These beneficial effects demonstrate the potential of probiotics in helping to treat obesity in children and adolescents, when undergoing dietary restrictions.

“Probiotic supplements are frequently given to people without proper evidence data. These findings start to give evidence of the efficacy and safety of two probiotic strains in treating obesity in a younger population,” Dr Prodam comments.

The study suggests that supplementation with probiotics could modify the gut microbiome environment and beneficially affect metabolism, helping obese children or adolescents who are also undergoing a restricted diet to lose weight. However, larger studies over a longer period of time are needed to investigate this.

Dr Prodam explains, “The next step for our research is to identify patients that could benefit from this probiotic treatment, with a view to creating a more personalised weight-loss strategy. We also want to decipher more clearly the role of diet and probiotics on microbiome composition. This could help us to understand how the microbiota is different in young people with obesity.”

 


---ENDS---

Abstract
2167
Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial
Arianna Solito, Iderina Hasballa, Matteo Calgaro, Nicole Bozzi Cionci, Roberta Ricotti, Marina Caputo, Giulia Genoni, Alice Monzani, Francesca Archero, Simonetta Bellone, Gianni Bona, Emanuela Agosti, Gianluca Aimaretti, Angela Amoruso, Marco Pane, Nicola Vitulo, Diana DI Gioia, Flavia Prodam

Background: Variations in gut microbiota might impact metabolic functions like caloric intake and energy expenditure leading to body weight excess. Microbiota modulation may be a potential approach for obesity management, especially in subject characterized by specific microbial enterotypes.

Objective: We aimed to assess the impact of probiotic treatment in obese children and adolescents, under diet control, on weight loss, glucose, and insulin homeostasis, gut microbiota composition and SCFAs.

Methods: This was a cross-over, double-blind, RCT on 100 children and adolescents (6-18 years) affected by obesity with insulin-resistance (NCT03261466). The subjects on dietary training were randomized to treatment with 2x109 CFU/AFU/die of Bifidobacterium breve BR03 (DSM 16604) and Bifidobacterium breve B632 (DSM 24706) or placebo for 8 weeks with a 4-weeks wash-out period. Clinical, biochemical and stool sample analyses were carried out at each time (T0-T3).

Results: At baseline, there were no differences in clinical and metabolic parameters between treatment and control group, except Escherichia coli concentration, which was higher in the placebo group. A mixed-effect model analysis revealed a carry-over effect on most of the variables, suggesting that the probiotic treatment had a prolonged effect over the washout period. Due to this event, only the results of the first phase (T0- T1) were deeply analyzed. For all the subjects (active and placebo) we observed significantly decreased BMI, BMI Z score, waist circumference (WC), systolic and diastolic blood pressure, insulin after OGTT, and E. Coli concentrations at T1. Probiotics further decreased WC (-3.51 cm, p<0.05), BMI Z score (-0.17 Kg/m2, p=0.07), fasting insulin (-4.57 mcUI/ml, p=0.06), HOMA IR (-1.1, p<0.05), E. Coli concentrations (p<0.02), and increased nearly to significance insulin sensitivity after OGTT. No differences were observed in inflammatory cytokines and GLP-1 levels at fasting. Of twenty-five SCFAs, probiotics decreased the 2-methyl- propanoic acid relative abundance (p<0.02). The PCoA analysis of SCFAs allowed defining four clusters of patients. Two clusters identified subjects that were healthier and had better responses in BMI Z score, WC, insulin resistance and sensitivity during probiotics.

Conclusions: Probiotic supplementation with B. breve BR03 and B632 has determined beneficial effects on weight and insulin metabolism in obese children and adolescents undergoing dietary training. Moreover, the microbiome-host configuration could be a predictor of the obesity phenotype and the efficacy of treatment with B. Breve strains.


Notes for Editors

The presentation, “Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial” was presented on Monday 7 September 2020 at 13:15 CET, online during e-ECE 2020.

e-ECE 2020 was held online on the 5-9 September. Catch up on ESE On-Demand.

The European Society of Endocrinology was created to promote research, education and clinical practice in endocrinology by the organisation of conferences, training courses and publications, by raising public awareness, liaison with national and international legislators, and by any other appropriate means.

Press

Vitamin D levels in the blood can predict future health risks & death
Skin lightening products linked to altered steroid hormone levels
Probiotics may help manage childhood obesity
Ghrelin may be an effective treatment for age-related muscle loss
Evaluating hormone-related targets & risks associated with COVID-19
Thyroid inflammation linked to anxiety disorders
COVID-19 severity is increased in patients with mild obesity
Larger thighs associated with lower risk of heart disease in obesity
Mindfulness helps obese children lose weight
Common anti-inflammatory may increase risk of diabetes
Vitamin B12 deficiency linked to obesity during pregnancy
Impaired liver function during pregnancy may increase risk of childhood obesity
Stress with disrupted body clock increases risk of metabolic disease
New insights into cause and treatments for aggressive form of breast cancer
Age is not a barrier to the benefits of weight-loss surgery
Limiting mealtimes may increase your motivation for exercise
Probiotic supplements may enhance weight loss in obese children
Smoking during pregnancy may damage daughters’ future fertility
Protective effect of breastfeeding on childhood obesity risk linked to leptin gene modification
Setting fair regulations for top female athletes that have naturally higher testosterone levels
Environmental toxins can impair sexual development and fertility of future generations
Sleep problems in teenagers reversed in just one week by limiting screen use
Men ignore serious health risks of steroid abuse in pursuit of the body beautiful
Obesity risk may be increased by exposure to common environmental chemicals
Breastfeeding reduces long-term risk of heart disease in mothers
Mentally tiring work may increase diabetes risk in women
Antioxidants may prevent cognitive impairment in diabetes
Skin inflammation may increase your risk of type-2 diabetes
Debate - Is the gut or the brain more important in regulating appetite and metabolism?
Routine vitamin B12 screening may prevent irreversible nerve damage in type-2 diabetes
Good nutrition could protect children from cognitive difficulties caused by early-life stress
Women more resilient to extreme physical activity than previously reported
Oestrogens in cows’ milk are unlikely to pose a threat to adult health
Diabetic patients are more at risk of death from alcohol, accidents and suicide
Too much vitamin A may increase risk of bone fractures
Vitamin D supplements may promote weight loss in obese children
Vitamin B supplements may protect kidney function in children with diabetes
Bad habits in childhood may lead to an ‘unhealthy’ balance of gut bacteria and increase health risks in later life
Lord Robert Winston cautions that advances in infertility therapies may be hindered by over-regulation
New link identified between inflammation and depression in type-1 diabetes
Walking a tightrope: universal thyroid testing could reduce pregnancy problems in some cases, but interfere with healthy pregnancies in others
Brain stimulation may reduce food cravings as obesity treatment
Larger waistlines are linked to higher risk of vitamin D deficiency
Transgender brains are more like their desired gender from an early age
Could intermittent fasting diets increase diabetes risk?
Minimising exposure to common hormone-disrupting chemicals may reduce obesity rates
Brain development disorders in children linked to common environmental toxin exposures
Children born to mothers with low vitamin D levels may develop autism-like behaviours
Over-the-counter antihistamines linked to impaired fertility in men
Arthritis drug can lower sugar levels in diabetes
Potential new target for reducing osteoporosis risk in men
Successful male infertility treatment does not lower fertility of sons
Warm temperatures can lead to misdiagnosis of diabetes in pregnancy
Guidelines for management of recurrent pituitary tumours recommend new drug as first line treatment
Taking paracetamol during pregnancy may reduce fertility of daughters
Link found between morning sickness, smoking and healthy pregnancies
High fat diet during childhood may increase PCOS risk later in life
Early pregnancy test for cows improves welfare and food production
International collaboration release revised guideline for improved management of Turner syndrome
Treating PCOS with a combination of oral contraceptives and spironolactone does not increase the risk of diabetes or heart disease
Vitamin D supplements could help pain management
Breast cancer risk is more affected by total body fat than abdominal fat
New nanotechnology application for difficult-to-treat cancers
Just six months of frequent exercise improves men’s sperm quality
Consuming more than two soft drinks a day can double risk of diabetes
Age-related scarring in ovaries may explain reproductive decline
Happy cows make more nutritious milk
Third of pregnant women iron deficient; risk thyroid-related pregnancy complications
New recommendations for the diagnosis and treatment of Adrenal Incidentalomas published in the European Journal of Endocrinology
Sitting down for long periods when pregnant linked to weight gain and depression
New drug provides safer alternative to conventional IVF treatment
Enzyme potential target for fight against obesity and diabetes
Bursts of high-intensity exercise could help diabetes patients manage low blood sugar levels
Soybean foods may protect menopausal women against osteoporosis
Vitamin D pill a day may improve exercise performance and lower risk of heart disease
Diabetes associated with increased risk of serious bacterial blood infection
Breast cancer risk higher in women with overactive thyroid
Injection of appetite gene may offer a more effective alternative to dieting
Hyperthyroidism could be great cost to countries in disability benefits
Mother’s hormone levels predict child’s ability to do maths